From advocacy to austerity: The new role of the U.S. public sector in HIV drug development and access
Sign Up to like & getrecommendations! Published in 2019 at "Global Public Health"
DOI: 10.1080/17441692.2019.1704820
Abstract: ABSTRACT Whereas advocacy was once the driving force for U.S. public support for HIV drug development and access, the nation’s response to the global epidemic is now shaped by austerity. Extending past scholarship about the… read more here.
Keywords: drug; drug development; austerity; development access ... See more keywords
From paediatric formulations development to access: Advances made and remaining challenges
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.15293
Abstract: Developing suitable paediatric formulations and ensuring access to them by the greatest number of the 2.2 billion children worldwide are equally important to provide optimal pharmacotherapy. This review focuses on the progress made over the… read more here.
Keywords: development access; paediatric formulations; formulations development; access advances ... See more keywords
Exploring Solutions to Foster ATMP Development and Access to Patients in Europe.
Sign Up to like & getrecommendations! Published in 2020 at "European journal of health law"
DOI: 10.1163/15718093-bja10016
Abstract: There are several critical factors that have influenced the (un)success rate of advanced therapy medicinal products (ATMPs) over the first ten years since the EU Regulation 1394/2007 entered into force. This article provides an overview… read more here.
Keywords: development; exploring solutions; foster atmp; development access ... See more keywords